Aesthetic
GLOW Blend
Three compounds – one ready-to-use research blend. GLOW Blend 70mg pairs GHK-Cu, BPC-157 and TB-500 in a Peptide Pen. Independently lab-tested for verified quality. Fast European and worldwide shipping.
€159.90 · 70mg
Available options
Product information
What it is GLOW combines GHK-Cu, BPC-157 and TB-500 in the same research blend. Most of the 70mg comes from GHK-Cu at 50mg. BPC-157 and TB-500 make up the remaining 20mg, with 10mg of each. They are three quite different compounds. GHK-Cu is a small copper-binding peptide, while BPC-157 has a 15-amino-acid sequence. TB-500 is different again. It is a short fragment linked to thymosin beta-4. Putting all three into GLOW doesn't turn them into a new peptide, and there isn't a single established mechanism that can be assigned to the blend as a whole. What the research shows A lot of the work on GHK-Cu concerns the extracellular matrix and what happens as tissue is remodelled. Collagen and fibroblast activity are part of that research, along with other changes taking place in the matrix. With BPC-157, the evidence looks different. Animal and laboratory studies make up most of the published research. Tissue injury and connective tissue models appear frequently, and angiogenesis has been investigated as well. There is very little human research by comparison. TB-500 is somewhat harder to separate from the literature around thymosin beta-4. The short sequence comes from a region of Tβ4 associated with actin, making cell movement and actin dynamics relevant areas of research. But much of the published work concerns full-length thymosin beta-4 rather than TB-500 itself. Those findings c